Welcome to Market Research Explore
MRE

Explore Market Research

Latest market research, industry analysis and market trend reports

Global Bio-pharma Market Research Report 2011-2023

Summary The global Bio-pharma market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows: Monoclonal Antibodies Recombinant Proteins Granulocyte-Colony Stimulating Factor (G-CSF) Interferons Recombinant Human Insulin Erythropoietin Vaccines Growth Hormones Purified Proteins Others Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows: Pfizer F. Hoffmann-La Roche AG Johnson & Johnson Services Sanofi, Amgen AbbVie Merck & Co. Biogen Idec Bayer AG Eli Lilly and Company Novartis AG GlaxoSmithKline Plc Bristol-Myers Squibb Company AstraZeneca PLC Abbott Laboratories Based on Application, the report describes major application share of regional market. Application mentioned as follows: Metabolic Disorders Oncology Neurological Disorders Cardiovascular Diseases Inflammatory and Infectious Diseases Others Based on region, the report describes major regions market by products and application. Regions mentioned as follows: Asia-Pacific North America Europe South America Middle East & Africa

Table of Contents 1 Market Overview 1.1 Objectives of Research 1.1.1 Definition 1.1.2 Specifications 1.2 Market Segment 1.2.1 by Type 1.2.1.1 Monoclonal Antibodies 1.2.1.2 Recombinant Proteins 1.2.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) 1.2.1.4 Interferons 1.2.1.5 Recombinant Human Insulin 1.2.1.6 Erythropoietin 1.2.1.7 Vaccines 1.2.1.8 Growth Hormones 1.2.1.9 Purified Proteins 1.2.1.10 Others 1.2.2 by Application 1.2.2.1 Metabolic Disorders 1.2.2.2 Oncology 1.2.2.3 Neurological Disorders 1.2.2.4 Cardiovascular Diseases 1.2.2.5 Inflammatory and Infectious Diseases 1.2.2.6 Others 1.2.3 by Regions 2 Industry Chain 2.1 Industry Chain Structure 2.2 Upstream 2.3 Market 2.3.1 SWOT 2.3.2 Dynamics 3 Environmental Analysis 3.1 Policy 3.2 Economic 3.3 Technology 3.4 Market Entry 4 Market Segmentation by Type 4.1 Market Size 4.1.1 Monoclonal Antibodies Market, 2011-2016 4.1.2 Recombinant Proteins Market, 2011-2016 4.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market, 2011-2016 4.1.4 Interferons Market, 2011-2016 4.1.5 Recombinant Human Insulin Market, 2011-2016 4.1.6 Erythropoietin Market, 2011-2016 4.1.7 Vaccines Market, 2011-2016 4.1.8 Growth Hormones Market, 2011-2016 4.1.9 Purified Proteins Market, 2011-2016 4.1.10 Others Market, 2011-2016 4.2 Market Forecast 4.2.1 Monoclonal Antibodies Market Forecast, 2017-2022 4.2.2 Recombinant Proteins Market Forecast, 2017-2022 4.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market Forecast, 2017-2022 4.2.4 Interferons Market Forecast, 2017-2022 4.2.5 Recombinant Human Insulin Market Forecast, 2017-2022 4.2.6 Erythropoietin Market Forecast, 2017-2022 4.2.7 Vaccines Market Forecast, 2017-2022 4.2.8 Growth Hormones Market Forecast, 2017-2022 4.2.9 Purified Proteins Market Forecast, 2017-2022 4.2.10 Others Market Forecast, 2017-2022 5 Market Segmentation by Application 5.1 Market Size 5.1.1 Metabolic Disorders Market, 2011-2016 5.1.2 Oncology Market, 2011-2016 5.1.3 Neurological Disorders Market, 2011-2016 5.1.4 Cardiovascular Diseases Market, 2011-2016 5.1.5 Inflammatory and Infectious Diseases Market, 2011-2016 5.1.6 Others Market, 2011-2016 5.2 Market Forecast 5.2.1 Metabolic Disorders Market Forecast, 2017-2022 5.2.2 Oncology Market Forecast, 2017-2022 5.2.3 Neurological Disorders Market Forecast, 2017-2022 5.2.4 Cardiovascular Diseases Market Forecast, 2017-2022 5.2.5 Inflammatory and Infectious Diseases Market Forecast, 2017-2022 5.2.6 Others Market Forecast, 2017-2022 6 Market Segmentation by Region 6.1 Market Size 6.1.1 Asia-Pacific 6.1.1.1 Asia-Pacific Market, 2011-2016 6.1.1.2 Asia-Pacific Market by Type 6.1.1.3 Asia-Pacific Market by Application 6.1.2 North America 6.1.2.1 North America Market, 2011-2016 6.1.2.2 North America Market by Type 6.1.2.3 North America Market by Application 6.1.3 Europe 6.1.3.1 Europe Market, 2011-2016 6.1.3.2 Europe Market by Type 6.1.3.3 Europe Market by Application 6.1.4 South America 6.1.4.1 South America Market, 2011-2016 6.1.4.2 South America Market by Type 6.1.4.3 South America Market by Application 6.1.5 Middle East & Africa 6.1.5.1 Middle East & Africa Market, 2011-2016 6.1.5.2 Middle East & Africa Market by Type 6.1.5.3 Middle East & Africa Market by Application 6.2 Market Forecast 6.2.1 Asia-Pacific Market Forecast, 2017-2022 6.2.2 North America Market Forecast, 2017-2022 6.2.3 Europe Market Forecast, 2017-2022 6.2.4 South America Market Forecast, 2017-2022 6.2.5 Middle East & Africa Market Forecast, 2017-2022 7 Market Competitive 7.1 Global Market by Vendors 7.2 Market Concentration 7.3 Price & Factors 7.4 Marketing Channel 8 Major Vendors 8.1 Pfizer 8.1.2 Profile 8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.2 F. Hoffmann-La Roche AG 8.2.1 Profile 8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.3 Johnson & Johnson Services 8.3.1 Profile 8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.4 Sanofi, Amgen 8.4.1 Profile 8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.5 AbbVie 8.5.1 Profile 8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.6 Merck & Co. 8.6.1 Profile 8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.7 Biogen Idec 8.7.1 Profile 8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.8 Bayer AG 8.8.1 Profile 8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.9 Eli Lilly and Company 8.9.1 Profile 8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.10 Novartis AG GlaxoSmithKline Plc 8.10.1 Profile 8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin) 8.11 Bristol-Myers Squibb Company 8.12 AstraZeneca PLC 8.13 Abbott Laboratories 9 Conclusion Table Product Specifications of Bio-pharma Table Products Segment of Bio-pharma Table Monoclonal Antibodies Overview Table Recombinant Proteins Overview Table Granulocyte-Colony Stimulating Factor (G-CSF) Overview Table Interferons Overview Table Recombinant Human Insulin Overview Table Erythropoietin Overview Table Vaccines Overview Table Growth Hormones Overview Table Purified Proteins Overview Table Others Overview Table Global Bio-pharma Market by Type, 2011-2022 (USD Million) Table Application Segment of Bio-pharma Table Metabolic Disorders Overview Table Oncology Overview Table Neurological Disorders Overview Table Cardiovascular Diseases Overview Table Inflammatory and Infectious Diseases Overview Table Others Overview Table Global Bio-pharma Market by Application, 2011-2022 (USD Million) Table Global Bio-pharma Market by Region, 2011-2022 (USD Million) Table Cost of Bio-pharma Table Market Dynamics Table Policy of Bio-pharma Table GDP of Major Countries Table Monoclonal Antibodies CAGR by Revenue and Volume, 2011-2016 Table Recombinant Proteins CAGR by Revenue and Volume, 2011-2016 Table Granulocyte-Colony Stimulating Factor (G-CSF) CAGR by Revenue and Volume, 2011-2016 Table Interferons CAGR by Revenue and Volume, 2011-2016 Table Recombinant Human Insulin CAGR by Revenue and Volume, 2011-2016 Table Erythropoietin CAGR by Revenue and Volume, 2011-2016 Table Vaccines CAGR by Revenue and Volume, 2011-2016 Table Growth Hormones CAGR by Revenue and Volume, 2011-2016 Table Purified Proteins CAGR by Revenue and Volume, 2011-2016 Table Others CAGR by Revenue and Volume, 2011-2016 Table Monoclonal Antibodies CAGR by Revenue and Volume, 2012-2022 Table Recombinant Proteins CAGR by Revenue and Volume, 2012-2022 Table Granulocyte-Colony Stimulating Factor (G-CSF) CAGR by Revenue and Volume, 2012-2022 Table Interferons CAGR by Revenue and Volume, 2012-2022 Table Recombinant Human Insulin CAGR by Revenue and Volume, 2012-2022 Table Erythropoietin CAGR by Revenue and Volume, 2012-2022 Table Vaccines CAGR by Revenue and Volume, 2012-2022 Table Growth Hormones CAGR by Revenue and Volume, 2012-2022 Table Purified Proteins CAGR by Revenue and Volume, 2012-2022 Table Others CAGR by Revenue and Volume, 2012-2022 Table Metabolic Disorders CAGR by Revenue and Volume, 2011-2016 Table Oncology CAGR by Revenue and Volume, 2011-2016 Table Neurological Disorders CAGR by Revenue and Volume, 2011-2016 Table Cardiovascular Diseases CAGR by Revenue and Volume, 2011-2016 Table Inflammatory and Infectious Diseases CAGR by Revenue and Volume, 2011-2016 Table Others CAGR by Revenue and Volume, 2011-2016 Figure Bio-pharma Picture Figure Industry Chain Structure of Bio-pharma Figure SWOT of Bio-pharma Figure Monoclonal Antibodies Market Size and Growth, 2011-2016 (USD Million) Figure Monoclonal Antibodies Market Size and Growth, 2011-2016 (in Volume) Figure Recombinant Proteins Market Size and Growth, 2011-2016 (USD Million) Figure Recombinant Proteins Market Size and Growth, 2011-2016 (in Volume) Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Size and Growth, 2011-2016 (USD Million) Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Size and Growth, 2011-2016 (in Volume) Figure Interferons Market Size and Growth, 2011-2016 (USD Million) Figure Interferons Market Size and Growth, 2011-2016 (in Volume) Figure Recombinant Human Insulin Market Size and Growth, 2011-2016 (USD Million) Figure Recombinant Human Insulin Market Size and Growth, 2011-2016 (in Volume) Figure Erythropoietin Market Size and Growth, 2011-2016 (USD Million) Figure Erythropoietin Market Size and Growth, 2011-2016 (in Volume) Figure Vaccines Market Size and Growth, 2011-2016 (USD Million) Figure Vaccines Market Size and Growth, 2011-2016 (in Volume) Figure Growth Hormones Market Size and Growth, 2011-2016 (USD Million) Figure Growth Hormones Market Size and Growth, 2011-2016 (in Volume) Figure Purified Proteins Market Size and Growth, 2011-2016 (USD Million) Figure Purified Proteins Market Size and Growth, 2011-2016 (in Volume) Figure Others Market Size and Growth, 2011-2016 (USD Million) Figure Others Market Size and Growth, 2011-2016 (in Volume) Figure Monoclonal Antibodies Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Monoclonal Antibodies Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Recombinant Proteins Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Recombinant Proteins Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Interferons Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Interferons Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Recombinant Human Insulin Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Recombinant Human Insulin Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Erythropoietin Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Erythropoietin Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Vaccines Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Vaccines Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Growth Hormones Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Growth Hormones Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Purified Proteins Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Purified Proteins Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Metabolic Disorders Market Size and Growth, 2011-2016 (USD Million) Figure Metabolic Disorders Market Size and Growth, 2011-2016 (in Volume) Figure Oncology Market Size and Growth, 2011-2016 (USD Million) Figure Oncology Market Size and Growth, 2011-2016 (in Volume) Figure Neurological Disorders Market Size and Growth, 2011-2016 (USD Million) Figure Neurological Disorders Market Size and Growth, 2011-2016 (in Volume) Figure Cardiovascular Diseases Market Size and Growth, 2011-2016 (USD Million) Figure Cardiovascular Diseases Market Size and Growth, 2011-2016 (in Volume) Figure Inflammatory and Infectious Diseases Market Size and Growth, 2011-2016 (USD Million) Figure Inflammatory and Infectious Diseases Market Size and Growth, 2011-2016 (in Volume) Figure Others Market Size and Growth, 2011-2016 (USD Million) Figure Others Market Size and Growth, 2011-2016 (in Volume) Figure Metabolic Disorders Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Metabolic Disorders Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Oncology Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Oncology Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Neurological Disorders Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Neurological Disorders Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Cardiovascular Diseases Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Cardiovascular Diseases Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Inflammatory and Infectious Diseases Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Inflammatory and Infectious Diseases Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million) Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume) Figure Asia-Pacific Market Size by Type Figure Asia-Pacific Market Share by Type Figure Asia-Pacific Market Size by Application Figure Asia-Pacific Market Share by Application Figure North America Market Size and Growth, 2011-2016 (USD Million) Figure North America Market Size and Growth, 2011-2016 (in Volume) Figure North America Market Size by Type Figure North America Market Share by Type Figure North America Market Size by Application Figure North America Market Share by Application Figure Europe Market Size and Growth, 2011-2016 (USD Million) Figure Europe Market Size and Growth, 2011-2016 (in Volume) Figure Europe Market Size by Type Figure Europe Market Share by Type Figure Europe Market Size by Application Figure Europe Market Share by Application Figure South America Market Size and Growth, 2011-2016 (USD Million) Figure South America Market Size and Growth, 2011-2016 (in Volume) Figure South America Market Size by Type Figure South America Market Share by Type Figure South America Market Size by Application Figure South America Market Share by Application Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million) Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume) Figure Middle East & Africa Market Size by Type Figure Middle East & Africa Market Share by Type Figure Middle East & Africa Market Size by Application Figure Middle East & Africa Market Share by Application Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume) Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million) Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume) Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million) Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million) Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume) Figure Bio-pharma Market Concentration by Region Figure Marketing Channels Overview


  Payment Mode
Single User 3610
Corporate User 5630

  About this Report
Category Chemicals & Materials
Published on 11/6/2017
Number of Pages 116
Over all Rating
"Rating is based on 113 reviews"